...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Bear

I agree with you entirely.That is why 3 months ago I called DM.I can't make the company do anything it is amazing to me that we have an IR department that seems to do very little when we are short of money.IR,PR we have very little.Frustrated that we are Halfpenny stock when you realise we have BTD.As I have said before if either #694 or 208 raised the dead we would have a small notice in the Obituaries and be sued by Undertakers.

Share
New Message
Please login to post a reply